+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Benefit Risk Appraisal"

PSUR/PBRER Online Training - Professional Training Program on Developing, Managing and Reporting of PSURs/PBRERs in Pharmacovigilance - Product Thumbnail Image

PSUR/PBRER Online Training - Professional Training Program on Developing, Managing and Reporting of PSURs/PBRERs in Pharmacovigilance

  • Training
  • Global
Pharmacovigilance: A Practical Approach - Product Thumbnail Image

Pharmacovigilance: A Practical Approach

  • Book
  • August 2018
  • 2 Results (Page 1 of 1)
Loading Indicator

The Benefit Risk Appraisal (BRA) market within the context of Drug Discovery is a rapidly growing industry. It is used to assess the potential risks and benefits of a drug before it is approved for use. BRA is used to evaluate the safety and efficacy of a drug, as well as its potential side effects. It also helps to identify any potential interactions with other drugs or treatments. BRA is used to ensure that the drug is safe and effective for its intended use. BRA is an important part of the drug discovery process, as it helps to ensure that the drug is safe and effective for its intended use. It also helps to identify any potential risks or benefits associated with the drug. BRA is used to assess the safety and efficacy of a drug, as well as its potential side effects. Companies in the BRA market include Quintiles, Parexel, Covance, ICON, and PPD. These companies provide services such as clinical trial design, data analysis, and regulatory consulting. They also provide services such as risk assessment, benefit-risk analysis, and drug safety monitoring. Show Less Read more